Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04JEH
|
|||
| Drug Name |
Aryl oxyanilide derivative 1
|
|||
| Synonyms |
PMID27607364-Compound-52
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
TAISHO PHARMACEUTICAL CO., LTD. NIHON, NOHYAKU CO., LTD. NAKAZATO, Atsuro OKUBO, Taketoshi NAKAMURA, Toshio CHAKI, Shigeyuki TOMISAWA, Kazuyuki NAGAMINE, Masashi YAMAMOTO, Kenji HARADA, Koichiro YOSHIDA, Masanori
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C24H24ClNO3
|
|||
| Canonical SMILES |
CC(C)OC1=CC=CC=C1CN(C2=C(C=C(C=C2)Cl)OC3=CC=CC=C3)C(=O)C
|
|||
| InChI |
1S/C24H24ClNO3/c1-17(2)28-23-12-8-7-9-19(23)16-26(18(3)27)22-14-13-20(25)15-24(22)29-21-10-5-4-6-11-21/h4-15,17H,16H2,1-3H3
|
|||
| InChIKey |
CGUBOFYHGYNUDL-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 220551-79-1
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Translocator protein (TSPO) | Target Info | Ligand | [1] |
| Target's Patent Info | Translocator protein (TSPO) | Target's Patent Info | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| HTLV-I infection | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010-2015; part 1).Expert Opin Ther Pat. 2016 Nov;26(11):1325-1351. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.